ALX Oncology Holdings Inc. (ALXO)
NASDAQ: ALXO · Real-Time Price · USD
1.240
+0.020 (1.64%)
Oct 30, 2026, 10:46 AM EDT - Market open
ALX Oncology Holdings Market Cap
ALX Oncology Holdings has a market cap or net worth of $171.46 million as of October 30, 2026. It is the 21,660th most valuable company in the world and the 3,721st biggest in the United States. Its market cap has increased by 101.38% in one year.
Market Cap
171.46M
Enterprise Value
44.27M
1-Year Change
101.38%
Global Rank
Country Rank
#3,721 United States
Category
ChartMarket Cap Chart
Since July 17, 2020, ALX Oncology Holdings's market cap has decreased from $1.06B to $171.46M, a decrease of -83.77%. That is a compound annual growth rate of -25.10%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2026 | 171.46M | 179.87% |
| Dec 31, 2025 | 61.27M | -30.44% |
| Dec 31, 2024 | 88.08M | -88.13% |
| Dec 29, 2023 | 741.80M | 61.50% |
| Dec 30, 2022 | 459.31M | -47.23% |
| Dec 31, 2021 | 870.34M | -74.66% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 17, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| NervGen Pharma | 159.13M |
| Entrada Therapeutics | 159.01M |
| MacroGenics | 155.43M |
| Upstream Bio | 152.81M |
| Canton Strategic Holdings | 152.19M |
| Sutro Biopharma | 147.07M |
| Satellos Bioscience | 146.07M |
| Protara Therapeutics | 145.97M |